Discovery of Orally Active, Potent, and Selective Benzotriazole-Based PTP1B Inhibitors

被引：25

作者：

Patel, Dipam ^{[1
,2
]}

Jain, Mukul ^{[1
]}

Shah, Shailesh R. ^{[2
]}

Bahekar, Rajesh ^{[1
]}

Jadav, Pradip ^{[1
]}

Darji, Brijesh ^{[1
]}

Siriki, Yernaidu ^{[1
]}

Bandyopadhyay, Debdutta ^{[1
]}

Joharapurkar, Amit ^{[1
]}

Kshirsagar, Samadhan ^{[1
]}

Patel, Harilal ^{[1
]}

Shaikh, Mubeen ^{[1
]}

Sairam, Kalapatapu V. V. M. ^{[1
]}

Patel, Pankaj ^{[1
]}

机构：

[1] Zydus Res Ctr, New Drug Discovery Div, Dept Med Chem, Ahmadabad 382210, Gujarat, India

[2] Maharaja Sayajirao Univ Baroda, Fac Sci, Dept Chem, Vadodara 390002, India

来源：

CHEMMEDCHEM | 2011年 / 6卷 / 06期

关键词：

benzotriazoles; inhibitors; metabolic disorders; PTP1B; TCPTP; TYROSINE-PHOSPHATASE; 1B; STRUCTURE-BASED DESIGN; INSULIN-RESISTANCE; STRUCTURAL BASIS; ACID; SENSITIVITY; GLYCEMIA; OBESITY;

D O I：

10.1002/cmdc.201100077

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A two-hand grasp on one enzyme: A novel series of dual-site benzotriazole derivatives are reported as potent PTP1B inhibitors. Some of the test compounds exhibit good selectivity for PTP1B over various other PTPs, including TCPTP (invitro), and the lead compound 10h shows excellent antidiabetic activity (invivo). © 2011 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

引用

页码：1011 / 1016

页数：6

共 50 条

[31] Discovery of highly functionalized 5,6-seco-grayanane diterpenoids as potent competitive PTP1B inhibitors
Zhou, Junfei
Zuo, Zhili
Liu, Junjun
Zhang, Hanqi
Zheng, Guijuan
Yao, Guangmin
ORGANIC CHEMISTRY FRONTIERS, 2020, 7 (06): : 820 - 828
[32] Discovery of potent and orally active tricyclic-based FBPase inhibitors
Tsukada, Tomoharu
Kanno, Osamu
Yamane, Takahiro
Tanaka, Jun
Yoshida, Taishi
Okuno, Akira
Shiiki, Takeshi
Takahashi, Mizuki
Nishi, Takahide
BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (14) : 5346 - 5351
[33] Discovery of Potent, Selective, and Orally Active Carboxylic Acid Based Inhibitors of Matrix Metalloproteinase-13
Monovich, Lauren G.
Tommasi, Ruben A.
Fujimoto, Roger A.
Blancuzzi, Vincent
Clark, Kirk
Cornell, Wendy D.
Doti, Robert
Doughty, John
Fang, James
Farley, David
Fitt, John
Ganu, Vishwas
Goldberg, Ronald
Goldstein, Robert
Lavoie, Stacey
Kulathila, Raviraj
Macchia, William
Parker, David T.
Melton, Richard
O'Byrne, Elizabeth
Pastor, Gary
Pellas, Theodore
Quadros, Elizabeth
Reel, Noela
Roland, Dennis M.
Sakane, Yumi
Singh, Hem
Skiles, Jerry
Somers, Joseph
Toscano, Karen
Wigg, Andrew
Zhou, Siyuan
Zhu, Lijuan
Shieh, Wen-Chung
Xue, Song
McQuire, Leslie W.
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (11) : 3523 - 3538
[34] Discovery of orally active, potent, and selective CB1 antagonists
Jayne, Charles L.
Xia, Yan
Vaccaro, Henry A.
Chackalamannil, Samuel
Greenlee, William
Boykow, George
Duffy, Ruth
Kowalski, Timothy
Spar, Brian
Cui, Xiaoming
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
[35] Discovery of [(3-bromo-7-cyano-2-naphthyl)(difluoro)-methyl]phosphonic acid, a potent and orally active small molecule PTP1B inhibitor
Han, Yongxin
Belley, Michel
Bayly, Christopher I.
Colucci, John
Dufresne, Claude
Giroux, Andre
Lau, Cheuk K.
Leblanc, Yves
Mckay, Daniel
Therien, Michel
Wilson, Marie-Claire
Skorey, Kathryn
Chan, Chi-Chung
Scapin, Giovana
Kennedy, Brian P.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (11) : 3200 - 3205
[36] Discovery of Novel PTP1B Inhibitors by High-throughput Virtual Screening
Debnath, Abhijit
Rani, Anjna
Mazumder, Rupa
Mazumder, Avijit
Singh, Rajesh Kumar
Sharma, Shalini
Srivastava, Shikha
Chaudhary, Hema
Mishra, Rashmi
Khurana, Navneet
Sanchitra, Jahanvi
Jan, Sk Ashif
CURRENT COMPUTER-AIDED DRUG DESIGN, 2024,
[37] Discovery of potent, selective, orally active, nonpeptide inhibitors of human mast cell chymase
Greco, Michael N.
Hawkins, Michael J.
Powell, Eugene T.
Almond, Harold R., Jr.
de Garavilla, Lawrence
Hall, Jeffrey
Minor, Lisa K.
Wang, Yuanping
Corcoran, Thomas W.
Di Cera, Enrico
Cantwell, Angelene M.
Savvides, Savvas N.
Damiano, Bruce P.
Maryanoff, Bruce E.
JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (08) : 1727 - 1730
[38] Toward the discovery of small molecule PTP1B inhibitors for the treatment of metabolic diseases
Nichols, Andrew J.
Mashal, Robert D.
Balkan, Bork
DRUG DEVELOPMENT RESEARCH, 2006, 67 (07) : 559 - 566
[39] Small Molecule Inhibitors of PTP1B and TCPTP
Reddy, Sekhar M. V. V. V.
Chakshusmathi, G.
Narasu, Lakshmi M.
RESEARCH JOURNAL OF BIOTECHNOLOGY, 2012, 7 (04): : 158 - 161
[40] Discovery and optimization of potent, selective, and orally bioavailable Jak1 inhibitors
Zak, Mark
Johnson, Adam
Van Abbema, Anne
Waszkowycz, Bohdan
Eigenbrot, Charles
Chang, Christine
Hurley, Christopher
Hanan, Emily
Kenny, Jane
Kulagowski, Janusz
DeVoss, Jason
Murray, Jeremy
Balazs, Mercedesz
Steffek, Micah
Koehler, Michael
Ghilardi, Nico
Chakravarty, Paroma
Lupardus, Patrick
Gibbons, Paul
Dragovich, Peter
Bergeron, Philippe
Pulk, Rebecca
Mendonca, Rohan
Savage, Scott
Labadie, Sharada
Gradl, Stefan
Ward, Stuart
Blair, Wade
Jia, Wei
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243

← 1 2 3 4 5 →